VPHIF (Valeo Pharma) Total Equity: $-45.96 Mil (As of Jul. 2024)


VPHIF Valeo Pharma Inc VPHIF
12 GF Score
Price $0.00
View Full Analysis

What is Valeo Pharma Total Equity?

Valeo Pharma VPHIF -99.00% 12 Total Equity is $-45.96 Mil as of Jul. 2024. GuruFocus rates VPHIF with a GF Score™ of 12/100.

Valeo Pharma's total equity for the quarter that ended in Jul. 2024 was $-45.96 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Valeo Pharma Total Equity Historical Data

* Premium members only.

The historical data trend for Valeo Pharma's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Valeo Pharma Total Equity Chart

Valeo Pharma Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Total Equity
Get a 7-Day Free Trial -0.02 2.32 1.65 -13.04 -29.42

Valeo Pharma Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -26.53 -29.42 -35.02 -40.13 -45.96
VPHIF
12GF Score
Valeo Pharma Inc VPHIF
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Valeo Pharma Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Valeo Pharma's Total Equity for the fiscal year that ended in Oct. 2023 is calculated as

Total Equity=Total Assets(Q: Oct. 2023 )-Total Liabilities(Q: Oct. 2023 )
=30.052-59.469
=-29.42

Valeo Pharma's Total Equity for the quarter that ended in Jul. 2024 is calculated as

Total Equity=Total Assets(Q: Jul. 2024 )-Total Liabilities(Q: Jul. 2024 )
=23.476-69.439
=-45.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $-45.96 Mil mean?
Valeo Pharma (VPHIF) has a Total Equity of $-45.96 Mil as of Jul. 2024. The total amount of equity as record on a company's balance sheet. View historical data for Valeo Pharma and its competitors.
Is Valeo Pharma's Total Equity too high?
Valeo Pharma's current Total Equity is $-45.96 Mil. Overall, Valeo Pharma has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Valeo Pharma's Total Equity compare to ZTS?
Valeo Pharma's Total Equity of $-45.96 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Valeo Pharma and its competitors. Valeo Pharma's current Total Equity is $-45.96 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Valeo Pharma stock overvalued right now?
Valeo Pharma (VPHIF) has a current Total Equity of $-45.96 Mil. The current Total Equity is $-45.96 Mil. Valeo Pharma's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Valeo Pharma (VPHIF), the current Total Equity is $-45.96 Mil as of Jul. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Valeo Pharma Business Description

Address 16667, Hymus Boulevard, Kirkland, QC, CAN, H9H 4R9
Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and hospital specialty products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.
12GF Score

Get the complete analysis for VPHIF

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price